Announcement
12 Feb 2021
In February 2021, the European Investment Bank (EIB) and OSE Immunotherapeutics signed a EUR 25 million (approx. USD 30.3 million) loan to support the company’s RDI activities.
Source
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
2 in force
Implementation date
12 Feb 2021
Revocation date:
No revocation date
On 12 February 2021, the European Investment Bank (EIB) and OSE Immunotherapeutics signed a EUR 25 million (approx. USD 30.3 million) loan to support the company’s RDI investment in the development of...
The EIB's loan for the amount of EUR 25 million (approx. USD 30.3 million) loan with OSE Immunotherapeutics, signed on 12 February 2021, formed part of the EIB’s strategy to support biotech companies ...
See all
This state act is not part of any Thread yet.